Besides, small molecule inhibitors targeting S100A9 were screened for therapeutic potential.<h4>Results</h4>Five DEGs, including S100A9, showed distinct expression patterns in children with obesity. This evidence concerns the gene S100A9 and obesity due to melanocortin 4 receptor deficiency.